Last checked at LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
BERENBERG RAISES BRITISH AMERICAN TOBACCO TO 'BUY' ('HOLD') - PRICE TARGET 5670 (5150) PENCE
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1510 (1506) PENCE - 'NEUTRAL'
----------
UBS CUTS BT GROUP PRICE TARGET TO 325 (400) PENCE - 'NEUTRAL'
----------
COMMERZBANK RAISES LONDON STOCK EXCHANGE GROUP TO 'BUY' ('HOLD') - PRICE TARGET 3700 (3100) PENCE
----------
JEFFERIES CUTS SMITH & NEPHEW PRICE TARGET TO 1350 (1370) PENCE - 'BUY'
----------
GOLDMAN CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 2400 (2680) PENCE - 'BUY'
----------
FTSE 250
----------
JEFFERIES RAISES VICTREX PRICE TARGET TO 2050 (1590) PENCE - 'HOLD'
----------
PANMURE CUTS SENIOR TO 'SELL' ('HOLD') - TARGET 160 (165) PENCE
----------
JPMORGAN RAISES ST MODWEN PROPERTIES PRICE TARGET TO 410 (380) PENCE - 'OW'
----------
SocGen Upgrades Pennon Group To Buy From Hold, Target 940p From 875p
----------
PANMURE CUTS GREENE KING PRICE TARGET TO 850 (1050) PENCE - 'BUY'
----------
BERENBERG CUTS TATE & LYLE PRICE TARGET TO 775 (810) PENCE - 'HOLD'
----------
JPMORGAN RAISES TATE & LYLE PRICE TARGET TO 730 (710) PENCE - 'NEUTRAL'
----------
HSBC CUTS DAIRY CREST GROUP PRICE TARGET TO 710 (750) PENCE - 'BUY'
----------
GOLDMAN CUTS WILLIAM HILL PRICE TARGET TO 290 (300) PENCE - 'SELL'
----------
UBS RAISES ASHMORE GROUP PRICE TARGET TO 390 (350) PENCE - 'BUY'
----------
JPMORGAN RAISES ASHMORE GROUP PRICE TARGET TO 305 (275) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2017 Alliance News Limited. All Rights Reserved.
3 Jan 2023 09:25
Hikma launches version of Xyrem medicine in US for treating narcolepsy
(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.
Read more
